dilazep has been researched along with Vertigo in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with vertebrobasilar insufficiency tend to develop transient, repeated vertigo." | 1.30 | Vertigo secondary to hypotension: the relationship between therapeutic effects and hearing. ( Ito, F; Kamada, H; Tanaka, K, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, F | 1 |
| Tanaka, K | 1 |
| Kamada, H | 1 |
1 other study available for dilazep and Vertigo
| Article | Year |
|---|---|
Vertigo secondary to hypotension: the relationship between therapeutic effects and hearing.
Topics: Adenosine Triphosphate; Adult; Aged; Audiometry, Pure-Tone; Diagnosis, Differential; Dilazep; Drug T | 1998 |